Cargando…
The early treatment and prognosis of epilepsy.
Recent community- and hospital-based studies of epilepsy from its onset suggest a much better prognosis than previously recognized, with about three-quarters of patients entering long-term remission on current medication. The first two years of medication are crucial in determining longer-term progn...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590307/ https://www.ncbi.nlm.nih.gov/pubmed/3577216 |
_version_ | 1782161289170124800 |
---|---|
author | Reynolds, E. H. |
author_facet | Reynolds, E. H. |
author_sort | Reynolds, E. H. |
collection | PubMed |
description | Recent community- and hospital-based studies of epilepsy from its onset suggest a much better prognosis than previously recognized, with about three-quarters of patients entering long-term remission on current medication. The first two years of medication are crucial in determining longer-term prognosis. Early effective therapy may be important in preventing the evolution of chronic epilepsy. Adverse prognostic factors include brain lesions, neuropsychiatric handicaps, and poor compliance. |
format | Text |
id | pubmed-2590307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1987 |
publisher | Yale Journal of Biology and Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-25903072008-11-28 The early treatment and prognosis of epilepsy. Reynolds, E. H. Yale J Biol Med Research Article Recent community- and hospital-based studies of epilepsy from its onset suggest a much better prognosis than previously recognized, with about three-quarters of patients entering long-term remission on current medication. The first two years of medication are crucial in determining longer-term prognosis. Early effective therapy may be important in preventing the evolution of chronic epilepsy. Adverse prognostic factors include brain lesions, neuropsychiatric handicaps, and poor compliance. Yale Journal of Biology and Medicine 1987 /pmc/articles/PMC2590307/ /pubmed/3577216 Text en |
spellingShingle | Research Article Reynolds, E. H. The early treatment and prognosis of epilepsy. |
title | The early treatment and prognosis of epilepsy. |
title_full | The early treatment and prognosis of epilepsy. |
title_fullStr | The early treatment and prognosis of epilepsy. |
title_full_unstemmed | The early treatment and prognosis of epilepsy. |
title_short | The early treatment and prognosis of epilepsy. |
title_sort | early treatment and prognosis of epilepsy. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590307/ https://www.ncbi.nlm.nih.gov/pubmed/3577216 |
work_keys_str_mv | AT reynoldseh theearlytreatmentandprognosisofepilepsy AT reynoldseh earlytreatmentandprognosisofepilepsy |